|
|||||
|
|
Hypomethylating agent therapy use and survival in older patients with chronic myelomonocytic leukemia in the United States: A large population‐based study |
|
| Authors: | Amer M. Zeidan MBBS MHS Xin Hu MSPH Jessica B. Long MPH Rong Wang PhD Xiaomei Ma PhD Nikolai A. Podoltsev MD PhD Scott F. Huntington MD MPH MSc Steven D. Gore MD Amy J. Davidoff PhD |
| Affiliation: | 1. Department of Internal Medicine, School of Medicine, Yale University, New Haven, Connecticut;2. Cancer Outcomes, Public Policy, and Effectiveness Research Center, Yale University, New Haven, Connecticut;3. Department of Chronic Disease Epidemiology, School of Public Health, Yale University, New Haven, Connecticut;4. Department of Health Policy and Management, School of Public Health, Yale University, New Haven, Connecticut |
| Abstract: | |
| Keywords: | azacitidine chronic myelomonocytic leukemia (CMML) decitabine effectiveness hypomethylating agents Medicare Surveillance Epidemiology and End Results (SEER) survival |